Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| agilon health, inc.AGL · Entity 4698 | Chief Legal Officer | August 01, 2026 | August 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
agilon health, inc.
Report date August 01, 2026 · Filed August 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 66,075 |
Reported balance
After 2026-08-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-01 · Tax withholding · Disposed 37 · Balance 66,075 F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2: Includes restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
F2: Includes restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2026 Filed Aug 4, 2026 20:23 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 37 | $91.61 | $3,389.57 |
DisclosureSEC source: 0001628280-26-052624 · wk-form4_1785875000.xml · nonDerivative · entry 1 Zamore Denise · CIK 0002062727 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,075 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. Read SEC document |
| June 01, 2026 Filed Jun 5, 2026 23:46 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 485 | $92.54 | $44,881.90 |
DisclosureSEC source: 0001628280-26-041353 · wk-form4_1780703200.xml · nonDerivative · entry 1 Zamore Denise · CIK 0002062727 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,112 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 00:12 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 220 | $26.88 | $5,913.60 |
DisclosureSEC source: 0001628280-26-025590 · wk-form4_1776384774.xml · nonDerivative · entry 2 Zamore Denise · CIK 0002062727 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,597 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2026 Filed Apr 17, 2026 00:12 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 20 | $22.68 | $453.60 |
DisclosureSEC source: 0001628280-26-025590 · wk-form4_1776384774.xml · nonDerivative · entry 1 Zamore Denise · CIK 0002062727 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,817 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 23:36 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023762 · wk-form4_1775259395.xml · nonDerivative · entry 2 Zamore Denise · CIK 0002062727 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,837 F3 · shares: Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment. F4 · balance_after: Includes restricted stock units. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 23:36 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 1,024 | $9.75 | $9,984.00 |
DisclosureSEC source: 0001628280-26-023762 · wk-form4_1775259395.xml · nonDerivative · entry 1 Zamore Denise · CIK 0002062727 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,837 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:50 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 2,056 | $0.60 | $1,233.39 |
DisclosureSEC source: 0001628280-26-016883 · wk-form4_1773262238.xml · nonDerivative · entry 2 Zamore Denise · CIK 0002062727 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 446,604 F4 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent a sale. F5 · balance_after: Includes restricted stock units. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:50 UTC | agilon health, inc. AGL · Entity 4698 | PurchaseCommon Stock | 5,535 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-016883 · wk-form4_1773262238.xml · nonDerivative · entry 1 Zamore Denise · CIK 0002062727 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 448,660 F1 · shares: This award was granted on April 14, 2023 and all remaining performance-based restricted stock units (PSUs) subject to the award vested on March 9, 2026. F2 · shares: The number of PSUs that vested was determined based on agilon health's predetermined Revenue and Adjusted EBITDA goals over a three-year period from January 1, 2023 through December 31, 2025. Total attainment achieved was 42%. F3 · price: Each PSU represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of PSUs in shares of common stock on their scheduled vesting date. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 21:10 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 915 | $1.70 | $1,555.50 |
DisclosureSEC source: 0001628280-25-037933 · wk-form4_1754428244.xml · nonDerivative · entry 1 Zamore Denise · CIK 0002062727 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 443,125 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 15, 2025 Filed Apr 17, 2025 00:48 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 5,490 | $5.53 | $30,359.70 |
DisclosureSEC source: 0001628280-25-018095 · wk-form4_1744850885.xml · nonDerivative · entry 2 Zamore Denise · CIK 0002062727 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 444,040 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2025 Filed Apr 17, 2025 00:48 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 517 | $5.60 | $2,895.20 |
DisclosureSEC source: 0001628280-25-018095 · wk-form4_1744850885.xml · nonDerivative · entry 1 Zamore Denise · CIK 0002062727 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 449,530 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 23:39 UTC | agilon health, inc. AGL · Entity 4698 | GrantOptions (Right to buy) · Derivative | 384,616 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001628280-25-016683 · wk-form4_1743723568.xml · derivative · entry 2 Zamore Denise · CIK 0002062727 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 384,616 Underlying: Common Stock · 384,616 shares Expires 2035-04-01 F4 · derivative.exercise_date: Options that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 23:39 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 245,099 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-016683 · wk-form4_1743723568.xml · nonDerivative · entry 1 Zamore Denise · CIK 0002062727 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,047 F1 · shares: Restricted stock units that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment. F2 · balance_after: Includes Performance Stock Units which may become vested subject to attainment (based on 40 trading day average closing price, exceeding twice the closing price of the Company's stock price on date of grant) and within three years from grant date. F3 · balance_after: Includes restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.